Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Oxi-Thyme is a healthcare technology company specializing in advanced environmental disinfection and decontamination solutions. The company utilizes a proprietary hyper-dry fogging system that disperses a hydrogen peroxide-based disinfectant to eliminate a broad spectrum of pathogens, including viruses, bacteria, and mold. Their technology is designed for use in hospitals, clinics, food processing facilities, and commercial spaces to ensure high-level biosafety. Oxi-Thyme's approach focuses on rapid, non-toxic, and residue-free sterilization of air and surfaces. The system is EPA-registered and has been widely deployed for COVID-19 remediation and general infection prevention.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxi-Thyme.